Thrivent Financial for Lutherans
HAE icon

Thrivent Financial for Lutherans’s Haemonetics HAE Stock Holding History

Thrivent Financial for Lutherans’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$590K Sell
10,470
-71
-0.7% -$4.62K ﹤0.01% 2145
2025
Q4 		$845K Sell
10,541
-528
-5% -$35.5K ﹤0.01% 2026
2025
Q3 		$540K Sell
11,069
-759
-6% -$47K ﹤0.01% 2049
2025
Q2 		$882K Buy
11,828
+49
+0.4% +$3.24K ﹤0.01% 1859
2025
Q1 		$749K Sell
11,779
-1,252,515
-99% -$85.2M ﹤0.01% 1884
2024
Q4 		$98.7M Buy
1,264,294
+164,111
+15% +$13.2M 0.19% 127
2024
Q3 		$88.4M Buy
1,100,183
+250,833
+30% +$20.3M 0.17% 160
2024
Q2 		$70.3M Buy
849,350
+836,623
+6,574% +$73.6M 0.14% 188
2024
Q1 		$1.09M Buy
12,727
+51
+0.4% +$4K ﹤0.01% 1865
2023
Q4 		$1.08M Sell
12,676
-22
-0.2% -$1.9K ﹤0.01% 1793
2023
Q3 		$1.14M Sell
12,698
-323
-2% -$28.8K ﹤0.01% 1662
2023
Q2 		$1.11M Sell
13,021
-293
-2% -$24.8K ﹤0.01% 1738
2023
Q1 		$1.1M Sell
13,314
-166
-1% -$13.4K ﹤0.01% 1723
2022
Q4 		$1.06M Sell
13,480
-102
-0.8% -$8.2K ﹤0.01% 1695
2022
Q3 		$1M Buy
13,582
+173
+1% +$12.4K ﹤0.01% 1683
2022
Q2 		$874K Buy
13,409
+53
+0.4% +$3.14K ﹤0.01% 1794
2022
Q1 		$844K Sell
13,356
-22,847
-63% -$1.24M ﹤0.01% 1924
2021
Q4 		$1.92M Buy
36,203
+18,251
+102% +$1.11M ﹤0.01% 1422
2021
Q3 		$1.27M Sell
17,952
-205
-1% -$12.9K ﹤0.01% 1677
2021
Q2 		$1.21M Sell
18,157
-53,422
-75% -$3.78M ﹤0.01% 1721
2021
Q1 		$7.95M Buy
71,579
+29,752
+71% +$3.68M 0.02% 748
2020
Q4 		$4.97M Sell
41,827
-40,848
-49% -$4.4M 0.01% 870
2020
Q3 		$7.21M Buy
82,675
+68,756
+494% +$6.01M 0.02% 695
2020
Q2 		$1.25M Buy
13,919
+676
+5% +$68.3K ﹤0.01% 1351
2020
Q1 		$1.32M Hold
13,243
– – ﹤0.01% 1151
2019
Q4 		$1.52M Buy
13,243
+61
+0.5% +$7.38K ﹤0.01% 1192
2019
Q3 		$1.66M Sell
13,182
-371
-3% -$47.1K 0.01% 1101
2019
Q2 		$1.63M Buy
13,553
+172
+1% +$16.9K 0.01% 1113
2019
Q1 		$1.17M Buy
13,381
+247
+2% +$22.5K ﹤0.01% 1266
2018
Q4 		$1.31M Buy
13,134
+543
+4% +$57K ﹤0.01% 1019
2018
Q3 		$1.44M Buy
12,591
+696
+6% +$72.1K ﹤0.01% 1059
2018
Q2 		$1.07M Sell
11,895
-24,118
-67% -$2.04M ﹤0.01% 1214
2018
Q1 		$2.63M Buy
36,013
+3,420
+10% +$235K 0.01% 805
2017
Q4 		$1.89M Buy
32,593
+643
+2% +$33.9K 0.01% 936
2017
Q3 		$1.43M Buy
31,950
+190
+0.6% +$7.89K 0.01% 990
2017
Q2 		$1.25M Sell
31,760
-128,600
-80% -$5.28M 0.01% 1010
2017
Q1 		$6.51M Buy
160,360
+132,580
+477% +$5.18M 0.03% 505
2016
Q4 		$1.12M Buy
27,780
+1,690
+6% +$63.7K 0.01% 1094
2016
Q3 		$945K Buy
26,090
+1,330
+5% +$45.7K ﹤0.01% 1155
2016
Q2 		$718K Sell
24,760
-64,510
-72% -$1.95M ﹤0.01% 1250
2016
Q1 		$3.12M Buy
89,270
+67,510
+310% +$2.18M 0.02% 746
2015
Q4 		$702K Buy
21,760
+710
+3% +$23K ﹤0.01% 1199
2015
Q3 		$680K Buy
21,050
+950
+5% +$35.8K ﹤0.01% 1085
2015
Q2 		$831K Buy
20,100
+1,100
+6% +$46.4K ﹤0.01% 887
2015
Q1 		$853K Buy
19,000
+200
+1% +$8.36K ﹤0.01% 887
2014
Q4 		$704K Buy
18,800
+50
+0.3% +$1.83K ﹤0.01% 953
2014
Q3 		$655K Sell
18,750
-300
-2% -$10.7K ﹤0.01% 984
2014
Q2 		$672K Buy
19,050
+150
+0.8% +$5.01K ﹤0.01% 1004
2014
Q1 		$616K Buy
18,900
+100
+0.5% +$3.82K ﹤0.01% 864
2013
Q4 		$792K Buy
18,800
+100
+0.5% +$4.12K ﹤0.01% 817
2013
Q3 		$746K Hold
18,700
– – ﹤0.01% 786
2013
Q2 		$773 Buy
+18,700
New +$757K 0.01% 762

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Thrivent Financial for Lutherans's HAE Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Haemonetics (HAE) stake by 0.67% in Q1 2026, selling an estimated $4.62K and leaving 10,470 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #2145.

Thrivent Financial for Lutherans first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $98.7M in Q4 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Thrivent Financial for Lutherans held 10,470 shares of Haemonetics worth $590K as of Q1 2026.
  • Thrivent Financial for Lutherans sold 71 Haemonetics shares in Q1 2026, an estimated $4.62K.
  • Haemonetics made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #2145 holding.
  • Thrivent Financial for Lutherans first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
  • Thrivent Financial for Lutherans's Haemonetics position peaked at $98.7M in Q4 2024.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.